Skip to main content

is part of the Informa Markets Division of Informa PLC

  • INFORMA PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PharmaConex
Pharmaconex
 

New Dates To Be Announced Soon!

Egypt International Exhibition Centre, Cairo, Egypt

  • OVERVIEW
    • EXHIBITION SECTORS
    • MARKET OVERVIEW
    • OUR COMMITMENT TO SUSTAINABILITY
  • VISIT
    • WHY VISIT
    • EXHIBITORS PROFILES
    • EXHIBITOR LIST 2020
  • EXHIBIT
    • STAND ENQUIRY
    • WHY EXHIBIT
    • VISITOR PROFILE
    • SPONSORSHIP
    • POST-SHOW REPORT
  • TRAVEL
  • MEDIA
    • MEDIA REGISTRATION
    • VIDEO GALLERY
    • PHOTO GALLERY
    • MEDIA PARTNERS
    • NEWS
  • CONFERENCES
    • CLEAN ROOM CONFERENCE
    • PHARMACONEX CONFERENCE
  • WEBINAR
    • PHARMACONEX WEBINAR-1
    • PHARMACONEX WEBINAR-2
  • CONTACT US

Active Pharmaceutical Ingredients & Generic APIs

An active pharmaceutical ingredient (API) is a drug or combination of drugs used in a finished pharmaceutical product which becomes the biologically active ingredient within the drug product intended for the diagnosis, treatment, or prevention of a disease.

The increasing incidence of chronic diseases growing importance of generics and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market.

The global active pharmaceutical ingredient market is estimated to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast period.

 

Last year`s exhibitors from this sector: 28%

Informa Markets

Copyright © 2020. All rights reserved. Informa Markets, a trading division of Informa PLC.

  • Accessibility|
  • Privacy Policy |
  • Cookie Policy|
  • Terms of Use|
  • Visitor Terms And Conditions